SG
BTAL icon

Sankala Group’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History

Sankala Group’s Portfolio BTAL Stock Details BTAL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$68.9K Buy
4,897
+3,157
+181% +$44.3K 0.06% 205
2025
Q4 		$24.5K Buy
+1,740
New +$26.2K 0.02% 295

Other funds holding BTAL

PPW
Pasadena Private Wealth Pasadena, California $723M AUM 18.72% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CCA
Carrera Capital Advisors Troy, Michigan $675M AUM 17.92% 1-Year Est. Return
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $89.9B AUM 20.5% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
CIBC World Market
CIBC World Market Toronto, Ontario, Canada $61.3B AUM 39.33% 1-Year Est. Return
AWM
AE Wealth Management Topeka, Kansas $21.5B AUM 26.98% 1-Year Est. Return
OIA
OneDigital Investment Advisors Overland Park, Kansas $11.8B AUM 21.23% 1-Year Est. Return
KF
Krilogy Financial St. Louis, Missouri $3.38B AUM 30.57% 1-Year Est. Return

Sankala Group's BTAL Position: Q1 2026 in Review

Sankala Group increased its AGF US Market Neutral Anti-Beta Fund (BTAL) stake by 181% in Q1 2026, buying an estimated $44.3K and bringing the position to 4,897 shares worth $68.9K. The position accounts for 0.06% of the portfolio, ranked #205.

Sankala Group first reported a position in BTAL in Q4 2025 and has held it in 2 quarters since. 87 funds tracked by Wall St. Rank hold BTAL as of Q1 2026.

  • Sankala Group held 4,897 shares of AGF US Market Neutral Anti-Beta Fund worth $68.9K as of Q1 2026.
  • Sankala Group bought 3,157 AGF US Market Neutral Anti-Beta Fund shares in Q1 2026, an estimated $44.3K.
  • AGF US Market Neutral Anti-Beta Fund made up 0.06% of Sankala Group's portfolio in Q1 2026, its #205 holding.
  • Sankala Group first reported a position in AGF US Market Neutral Anti-Beta Fund in Q4 2025 and has held it in 2 quarters since.
  • 87 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q1 2026.

Based on Sankala Group's 13F filing for Q1 2026, filed 31 Mar 2026.